Form 4 for TNGX Tango Therapeutics, Inc.
Accepted 2024-06-07 00:00:00 ET · period of report 2024-06-05 · accession 0000950170-24-070906 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-07 | 2024-06-05 | TNGX | Peters Malte | Dir | A - Grant | $0.00 | +6,250 | 11.2K | +125% | $0 |
| D | 2024-06-07 | 2024-06-05 | TNGX | Peters Malte | Dir | A - Grant | $0.00 | +37.5K | 37.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-05 | A | A | 6,250 | $0.00 | 11,250 | D | — | — | (F1) These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in its entirety on the earlier of: (i) June 5, 2025 and (iii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-06-05 | A | A | 37,500 | $0.00 | 37,500 | D | $7.41 · — to 2034-06-05 | 37,500 Common Stock | (F2) This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year beginning on July 5, 2024, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date. |